Janssen to Highlight Science

Janssen to Highlight Science, Innovation and Advances in Robust ...

Studies spanning industry-leading hematologic malignancies portfolio and pipeline with new research in solid tumor therapies to highlight precision medicine ...

Janssen to Highlight Scientific Advances and Commitment to ...

The 2023 American Society of Clinical Oncology (ASCO) Annual Meeting will feature 50 presentations from the Company's robust oncology portfolio and pipeline.

Janssen to Highlight Commitment to Lung Cancer Science and ...

Updated amivantamab data from the Phase 1 CHRYSALIS study and new data characterizing the high unmet need among patients with non-small cell lung cancer ...

Janssen to Highlight Latest Scientific Advances in Hematologic ...

Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and ...

Janssen - Johnson & Johnson Innovative Medicine

Data highlights strength of multi-target, multi-platform multiple myeloma portfolio and continued innovation in B-cell malignancies to transform patient ...

Janssen to Highlight Science, Innovation and Advances in Robust ...

IMBRUVICA® blocks the Bruton's tyrosine kinase (BTK) protein, which is needed by normal and abnormal B cells, including specific cancer cells, ...

ASCO 2022 | Janssen

D. Global Therapeutic Area Head Oncology Janssen Research & Development, LLC. Tyrone Brewer U.S. President Oncology ... Highlight Science, Innovation and ...

Janssen to Highlight Latest Scientific Advances in Hematologic ...

The most frequently reported adverse reactions (incidence ≥20%) were: upper respiratory infection, neutropenia, infusion‑related reactions, ...

Welcome to Janssen Science™

Janssen Science™ is the site to access current scientific information about Janssen products.

Janssen to Showcase Commitment to Advancing Science for ...

... highlighted at the virtual 2021 American Urological Association Annual Meeting (AUA 2021), September 10-13. "Janssen maintains a strong commitment to ...

Turning Data Science from Abstract to Reality, with Janssen

Dr Khan is Chief Data Science Officer and Global Head of Strategy and Operations for Janssen Research and Development. March 7, 2022. Archive Highlight: Turning ...

Johnson & Johnson : Janssen to Highlight Scientific Advances and ...

Johnson & Johnson : Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 ...

Janssen Demonstrates Commitment to Transform the Treatment of ...

... highlight latest data across biologic ... The research presented at IMS represents Janssen's 20-year commitment to advance the science ...

related announcements - Public now

Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing ...

Janssen Oncology Newsroom

We feature presentations from our oncology portfolio and pipeline, highlighting important efforts to advance science and improve outcomes across multiple ...

Independent Medical Education - Janssen Science

Can Molecular Testing Identify Which mNSCLC Patients Will Benefit From New Targeted Tx? Clinical Trials: How They Transform the Treatment of Cancer · Highlights ...

Dr. Paul Janssen Award: Home

Paul Janssen Award for Biomedical Research honors scientists who have made a ... Select All Vendors. Select All Vendors. All Consent Allowed. host ...

Janssen Aims to Define New Standards of Care in the Treatment of ...

“The data and results premiering at this year's ESMO represent our determination to advance oncology science and set new innovation standards in ...

Reinier Janssen - JPL Science - NASA

Reinier Janssen combines the study of active galactic nuclei (AGN) and ... Highlights · Workshops · NASA; |; Caltech; |; Privacy; |; Image Policy; |; Feedback.

CARVYKTI-pi.pdf - Janssen

HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use CARVYKTI safely and effectively.